Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial iron acquisition and metabolic proteins comprise a group of bacterial outer membrane receptors, transporters, enzymes, and regulators involved in the uptake, transport, and utilization of iron, an essential micronutrient for microbial growth and pathogenicity[1][2][3][4][5]. These include transferrin-binding proteins (TbpA, TbpB), lactoferrin-binding proteins (LbpA, LbpB), receptors for siderophores, hemoproteins, and iron-sulfur clusters, as well as associated ABC transporters and regulatory proteins such as the ferric uptake regulator (Fur)[1][2][3][5][6]. Functionally, these proteins allow bacteria to scavenge iron from host sources (e.g., transferrin, lactoferrin, heme), a process critical for their survival in iron-limited environments such as the human host[1][3][4][5]. Because of their centrality to microbial survival and virulence, iron acquisition proteins are considered promising targets for novel antimicrobials, including drugs that block iron uptake or use siderophore-mediated antibiotic delivery (e.g., cefiderocol)[3][4]. The systems themselves are diverse and species-specific, and the broad, unspecific category "Microbial iron acquisition and metabolic proteins" refers to families of related yet distinct proteins, rather than a single target—precise targeting or drug development efforts typically address specific members such as TbpA, LbpA, or Fur rather than this collective[1][2][3][4][5]. This entry is **too broad and not a standardized molecular target name**, as it groups multiple protein families and mechanisms. Each component (e.g., TbpA, Fur) has different functions, structures, and clinical relevance. For clear scientific or drug development purposes, it is preferable to refer to individual, well-defined proteins or transporter systems.
Blockade of iron uptake by competitive inhibition of iron-binding or transport; Siderophore mimicry to deliver antibiotics ("Trojan horse" strategy); Inhibition of transcriptional or metabolic regulators (e.g., Fur antagonists); Disruption of iron homeostasis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial iron acquisition protein.